Metastatic Liver Disease - Presenting as Multiple Hepatic Cysts
Journal Title: Liver Research – Open Journal - Year 2015, Vol 1, Issue 1
Abstract
A 59 year-old woman with a history of successfully treated Hepatitis-C, Systemic Lupus Erythematosus, and a remote history of melanoma of the scalp presented to our center for evaluation of abdominal pain, nausea, vomiting, and malaise. An outpatient CT scan revealed numerous cystic liver lesions. A liver ultrasound from one year prior to admission showed a mildly heterogeneous and echogenic liver texture with no observed masses or dilated ducts. Her genotype 1b Hepatitis-C virus had been successfully treated with Pegylated interferon, Ribavirin, and Telaprevir 9 months prior to presentation. A liver biopsy revealed stage I fibrosis 6 months prior to presentation.
Authors and Affiliations
Parvez Mantry
Keywords
Related Articles
- EP ID EP556429
- DOI 10.17140/LROJ-1-102
- Views 155
- Downloads 0
Cardiovascular Disease and NASH
Non-alcoholic fatty liver disease (NAFLD) and Non-alcoholic steatohepatitis (NASH) are associated with cardiovascular events and Metabolic Syndrome (MetS). NAFLD is considered to be a hepatic manifestation of MetS and ha...
Pediatric Acute Liver Failure: Current Perspectives
It is well known that acute liver failure (ALF) in children is rare but potentially a life-threatening disorder. Its true incidence in the pediatric population is undetermined but is responsible for 10-15% of all pediatr...
Comparisons between Portosystemic Shunting Modalities in Patients with Liver Cirrhosis and Portal Hypertension
During almost half of century period, in the Department of Surgery of Portal Hypertension and Pancreatoduodenal Zone of the JSC “Republican Specialized Center of Surgery (named after Academician V. Vakhidov”), portosyste...
Targeted Therapy for Hepatocellular Carcinoma: What`s New?
Hepatocellular carcinoma (HCC), one of the most frequent neoplasms worldwide, causes more than 700,000 deaths per year, and is the third cause of cancer-related mortality.1-3 HCC occurs after years of damage to hepatocyt...
The Prescribers’ Dilemma: Treatment of Hepatitis C Infection for Medicaid Insured Patients in United States
Introduction of Direct Acting Antivirals (DAA) to Hepatitis C Virus (HCV) treatment armamentarium has offered a great boost to the providers’ confidence to safely and effectively treat HCV infection in the majority of pa...